Eye Drop

Hickory Dickory Dock, a well-known nursery rhyme, is a nonsense poem in which children mimic the sound of a clock chiming at the relevant point in the song, intending to introduce the fundamentals of telling time.

Patient recruitment and screening are underway in the LYNX-1 phase 3 registration study to investigate the safety and efficacy of Nyxol for night vision disturbances, Ocuphire Pharma announced in a press release.

Patients with moderate to severe dry eye disease experienced statistically significant improvement in signs and symptoms after 2 weeks of dosing with PL9643 and at the 12-week visit, Palatin Technologies announced in a press release.

In this Healio Video Perspective from the virtual AAO annual meeting, Michael R. Robinson, MD, vice president, global therapeutic area head, ophthalmology, AbbVie, breaks down studies investigating presbyopia-treating eye drops.

In this Healio Video Perspective from the virtual Eyecelerator conference, Ben Bergo, president and CEO, Visus Therapeutics, outlines the mechanism and clinical data of Brimochol, the company’s lead presbyopia-correcting eye drop candidate.

Results from a phase 2b study of a pilocarpine and oxymetazoline combined topical eye drop for the treatment of presbyopia significantly improved uncorrected near visual acuity.

A phase 2b clinical trial of AR-15512 ophthalmic solution for the treatment of dry eye disease has been initiated, according to a press release from Aerie Pharmaceuticals.

There is a lot of excitement around the new eye drops for presbyopia, which should hopefully become available in the U.S. in the next 1 to 2 years. The beauty of this pharmacological option is that patients can try the drops and determine how effective they are and how well they tolerate them before committing to long-term use. It is the least invasive and easiest way to reverse the symptoms of presbyopia and reduce the need for reading glasses, with no known long-term downside or risk. Once available, patients will have the option to trial these medications. If not satisfied with the level of improvement in reading vision, or if the side effects are not well tolerated, patients can, of course, elect surgical options to improve their reading vision.